NTLA-2001
Intellia Therapeutics
['cardiomyopathy', 'cardio', 'crispr']
#jaccbts eic dr. discussed w/ the findings from the #aha22 late-breaker first-in-human in vivo crispr/cas9 editing of the ttr gene by ntla-2001 in patients with transthyretin amyloidosis with cardiomyopathy" watch the video here: 
The latest news from the American College of Cardiology (ACC) and the ?? of cardiovascular health. Follow @ACCinTouch for other ACC updates.